Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease

Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease

ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect...

Full description

Bibliographic Details
Main Authors: Yanyan Li, Na Zhu, Xinyu Cui, Yingying Lin, Xin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus-2
ursodeoxycholic acid
chronic liver disease
infection
propensity score matching analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1178590/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1178590/full

Similar Items